MedPath

Effects of Selective Laser Trabeculoplasty

Terminated
Conditions
Glaucoma
Interventions
Procedure: Surgery
Procedure: Selective Laser Trabeculoplasty
Registration Number
NCT00986141
Lead Sponsor
University of Kentucky
Brief Summary

Primary objective is to evaluate the effect of selective laser trabeculoplasty (SLT) on the diurnal intraocular pressure variation in open-angle glaucoma patients (OAG).

Detailed Description

This is a prospective observational study of OAG patients undergoing selective laser trabeculoplasty at the University of Kentucky Chandler Medical Center. The patients will be recruited over 12 months. Study will include 3 visits: pre-laser visit, visit for laser treatment and post-laser visit. All visits will occur within a 3-month period.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Subjects who have the diagnosis of open angle glaucoma
  • Subjects who are able to speak and understand English and provide meaningful written informed consent,
  • Subjects who are willing and able to comply with all testing and requirements defined in the protocol and willing and able to comply with all required study visits.
Exclusion Criteria
  • Subjects with previous laser treatment or intraocular surgery,
  • Subjects with history of ocular inflammation and with history of previous ocular trauma.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
laser trabeculoplastySelective Laser TrabeculoplastySubjects with POAG and on medical treatment who are undergoing SLT
laser trabeculoplastySurgerySubjects with POAG and on medical treatment who are undergoing SLT
Primary Outcome Measures
NameTimeMethod
To evaluate the effect of selective laser trabeculoplasty on the diurnal intraocular pressure variation in OAG patients.Three years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Kentucky

🇺🇸

Lexington, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath